These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 33206922)

  • 1. [Adverse events following immunization against influenza the in elderly in Brazil].
    Rodrigues D; de Marchi Bacellos de Dalri RC
    Rev Salud Publica (Bogota); 2019 Jan; 21(1):22-28. PubMed ID: 33206922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occurrence of early adverse events after vaccination against influenza at a Brazilian reference center.
    Lopes MH; Mascheretti M; Franco MM; Vasconcelos R; Gutierrez EB
    Clinics (Sao Paulo); 2008 Feb; 63(1):21-6. PubMed ID: 18305872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Post-vaccination adverse events in the elderly in the State of São Paulo, Brazil, 2015 to 2017].
    Santos LCBD; Silva HSD; Borja-Oliveira CR; Chubaci RYS; Gutierrez BAO
    Cad Saude Publica; 2021; 37(4):e00084820. PubMed ID: 33978110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity and safety of Southern Hemisphere inactivated quadrivalent influenza vaccine: a Phase III, open-label study of adults in Brazil.
    Zerbini CA; Ribeiro Dos Santos R; Jose Nunes M; Soni J; Li P; Jain VK; Ofori-Anyinam O
    Braz J Infect Dis; 2017; 21(1):63-70. PubMed ID: 27912069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fever following immunization with influenza A (H1N1) vaccine in children: a survey-based study in the Netherlands.
    Broos N; van Puijenbroek EP; van Grootheest K
    Drug Saf; 2010 Dec; 33(12):1109-15. PubMed ID: 21077701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of adverse events among healthcare workers following H1N1 Mass immunization in Ghana: a prospective study.
    Ankrah DN; Mantel-Teeuwisse AK; De Bruin ML; Amoo PK; Ofei-Palm CN; Agyepong I; Leufkens HG
    Drug Saf; 2013 Apr; 36(4):259-66. PubMed ID: 23508545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spontaneous reporting of adverse events following pandemic influenza A (H1N1) immunization in a reference center in the State of São Paulo, Brazil.
    Oliveira DS; Lara AN; Luiz AM; Miyaji KT; Sartori AM; Lopes MH
    Rev Soc Bras Med Trop; 2013; 46(3):348-51. PubMed ID: 23856866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influenza vaccination in non-institutionalized elderly: a population-based study in a medium-sized city in Southern Brazil.
    Dip RM; Cabrera MA
    Cad Saude Publica; 2010 May; 26(5):1035-44. PubMed ID: 20563403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of adverse events following immunization with pandemic influenza A (H1N1)pdm09 vaccine with or without adjuvant among health professionals in Rio de Janeiro, Brazil.
    Cerbino-Neto J; Santos AT; Gouvea MI; Pedro RS; Ramos GV; Guaraldo L; Werneck GL
    Mem Inst Oswaldo Cruz; 2012 Nov; 107(7):923-7. PubMed ID: 23147150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination against influenza in elderly people: factors associated with acceptance and refusal of the vaccine.
    Pinto CJM; Pereira EHR; Teodoro CM; Becari RA; Assis VG; Ferrari JC; Hoehne EL
    Rev Soc Bras Med Trop; 2019 Mar; 52():e20180366. PubMed ID: 30892550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the adverse events following immunization with inactivated quadrivalent influenza vaccine from 2018 to 2020 in Zhejiang province, with a comparison to trivalent influenza vaccine.
    Lv H; Pan X; Liang H; Wang Y; Hu Y
    Hum Vaccin Immunother; 2021 Nov; 17(11):4617-4622. PubMed ID: 34491888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-licensure surveillance of trivalent adjuvanted influenza vaccine (aIIV3; Fluad), Vaccine Adverse Event Reporting System (VAERS), United States, July 2016-June 2018.
    Haber P; Moro PL; Ng C; Dores GM; Lewis P; Cano M
    Vaccine; 2019 Mar; 37(11):1516-1520. PubMed ID: 30739795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active surveillance of adverse events following immunization against pandemic influenza A (H1N1) in Korea.
    Choe YJ; Cho H; Song KM; Kim JH; Han OP; Kwon YH; Bae GR; Lee HJ; Lee JK
    Jpn J Infect Dis; 2011; 64(4):297-303. PubMed ID: 21788704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of a universal influenza A vaccine (MVA-NP+M1) in adults when given after seasonal quadrivalent influenza vaccine immunisation (FLU009): a phase 2b, randomised, double-blind trial.
    Evans TG; Bussey L; Eagling-Vose E; Rutkowski K; Ellis C; Argent C; Griffin P; Kim J; Thackwray S; Shakib S; Doughty J; Gillies J; Wu J; Druce J; Pryor M; Gilbert S
    Lancet Infect Dis; 2022 Jun; 22(6):857-866. PubMed ID: 35305317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of response rates on invitation mode of a web-based survey on influenza vaccine adverse events among healthcare workers: a pilot study.
    Tai X; Smith AM; McGeer AJ; Dubé E; Holness DL; Katz K; McGillis Hall L; McNeil SA; Powis J; Coleman BL
    BMC Med Res Methodol; 2018 Jun; 18(1):59. PubMed ID: 29925324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccines for preventing influenza in the elderly.
    Demicheli V; Jefferson T; Di Pietrantonj C; Ferroni E; Thorning S; Thomas RE; Rivetti A
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD004876. PubMed ID: 29388197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Postmarket Safety Profile of Adjuvanted and High-Dose Influenza Vaccines in Individuals 65 Years or Older.
    Pillsbury AJ; Fathima P; Quinn HE; Cashman P; Blyth CC; Leeb A; Macartney KK
    JAMA Netw Open; 2020 May; 3(5):e204079. PubMed ID: 32369177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful methodology for large-scale surveillance of severe events following influenza vaccination in Canada, 2011 and 2012.
    Bettinger JA; Rouleau I; Gariepy MC; Bowie WR; Valiquette L; Vanderkooi OG; Kellner JD; Coleman BL; McNeil SA; McCarthy A; De Serres G;
    Euro Surveill; 2015 Jul; 20(29):21189. PubMed ID: 26227369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse events following pandemic influenza A (H1N1) 2009 monovalent and seasonal influenza vaccinations during the 2009-2010 season in the active component U.S. military and civilians aged 17-44years reported to the Vaccine Adverse Event Reporting System.
    Bardenheier BH; Duderstadt SK; Engler RJ; McNeil MM
    Vaccine; 2016 Aug; 34(37):4406-14. PubMed ID: 27449076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ontology-based combinatorial comparative analysis of adverse events associated with killed and live influenza vaccines.
    Sarntivijai S; Xiang Z; Shedden KA; Markel H; Omenn GS; Athey BD; He Y
    PLoS One; 2012; 7(11):e49941. PubMed ID: 23209624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.